TYMS and non-small cell lung carcinoma: The results of their study show that patients who received platinum-based adjuvant chemotherapy in combination with paclitaxel or gemcitabine had shorter disease-free intervals and overall survival rates than patients with a high expression of TS in NSCLC [24].